NEO NeoGenomics Laboratories, Inc.
$14.82 -1.79%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Point at or drag across the chart to read a day. EOD data.
1D
-1.79%
YTD
+26.00%
P/E
—
P/B
1.82
ROE
-4%
Div yield
—
Beta
1.1
Market cap
$2.0B
RSI (14)
34
Next earnings
Feb 15, 2027
Same sector · Health Care
Compare NEO with NVO and JNJ →Follow NEO in the AlfaCat app
Watchlist, price and earnings alerts, the chart offline. Free, no account, no ads.
The economy behind it · United States
Economy this week on BullDozer →GDP, % on year
2.1
Q3 2026
Inflation, %
3.7
Sep 2026
Unemployment, %
3.9
Oct 2026
10-yr yield, %
5.13
Oct 2026
From BullDozer, our sister site for country statistics (open sources: OECD, IMF, Eurostat, ILO). Full United States profile →
Previous session
close of Nov 20, 2026 · EOD, no live order bookOpen
$14.86
Close
$14.82
Day high
$15.14
Day low
$14.63
Volume
1.2M
Latest headlines
Did Narrower Quarterly Loss Just Shift NeoGenomics Stock Investment Narrative?
Yahoo Finance · Nov 6
NEO Q3 deep dive: product mix shift and margin expansion drive robust oncology testing growth
Yahoo Finance · Nov 3
5 revealing analyst questions from NeoGenomics’s Q3 earnings call
Yahoo Finance · Oct 31
NeoGenomics (NEO) Beat Q3 Expectations, Is The Stock Still Cheap?
Yahoo Finance · Oct 29
What NeoGenomics (NEO) Said on Its Q3 Earnings Call
Yahoo Finance · Oct 29
NeoGenomics (NEO) Q3 2026 Earnings Call Transcript
Yahoo Finance · Oct 29
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Oct 28, 2026 View → 8-K Oct 28, 2026 View → 8-K Oct 5, 2026 View → 8-K Aug 11, 2026 View → 10-Q Jul 28, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell NEO. Try it in the Lab to size a position and see the risk.